$SGEN Headlines Fossil shares rise as earnings
Post# of 44845
Posted On: 06/21/2014 4:32:25 PM
$SGEN Headlines
Fossil shares rise as earnings beat Street 6:55 p.m. Feb. 11, 2014 - Wallace Witkowski
December pullback triggers first technical test 12:33 p.m. Dec. 5, 2013 - Michael Ashbaugh
Six stocks to watch for some upside 3:21 p.m. April 11, 2013 - The Trading Deck
S&P 500 takes flight, reaches record territory 10:55 a.m. April 11, 2013 - Michael Ashbaugh
Five bullish charts to watch 4:15 p.m. March 7, 2013 - The Trading Deck
Thursday’s biggest movers; Apple at 5-month low 6:27 p.m. Nov. 8, 2012 - Sue Chang
Hot Stocks to watch 7:27 a.m. Aug. 9, 2012 - MarketWatch.com
2012 biotech medal winners ... so far 12:01 a.m. Aug. 1, 2012 - Gil Morales
12 biotech stocks hit 52-week highs 3:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three technical tests converge 10:40 a.m. July 18, 2012 - Michael Ashbaugh
MoKa's Morales sees Facebook, LinkedIn on cutting edge 12:34 p.m. June 25, 2012 - blogs.marketwatch.com
Tuesday’s biggest gaining and declining stocks 6:47 p.m. Feb. 14, 2012 - Sue Chang
Rackspace Hosting, Yingli rise after hours 6:44 p.m. Feb. 13, 2012 - Myra P. Saefong
Seattle Genetics falls on growth concerns 2:42 p.m. Nov. 4, 2011 - MarketWatch.com
ECB rattles the technical backdrop 10:45 a.m. Nov. 3, 2011 - Michael Ashbaugh
U.S. markets break from the “crash” range 12:19 p.m. Oct. 24, 2011 - Michael Ashbaugh
S&P 500 rattles the cage on a trend shift 10:35 a.m. Oct. 10, 2011 - Michael Ashbaugh
3 biotech stocks battle the ‘Dendreon Effect’ 7:50 p.m. Aug. 18, 2011 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 3:49 p.m. July 15, 2011 - Kate Gibson
Seattle Genetics slides 11% on drug launch worries 10:06 a.m. July 15, 2011 - Val Brickates Kennedy
Hottest Healthcare Stocks Now – ISIS CELG MDT COV 7:00 a.m. June 19, 2014 - InvestorPlace.com
Can the Rally in Seattle Genetics (SGEN) Shares Continue? - Tale of the Tape 9:52 a.m. June 12, 2014 - Zacks.com
Biotech Stocks Get Turbo Boost From Idenix Deal 6:45 p.m. June 11, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ALNY SGEN PBYI RDY 9:00 a.m. June 11, 2014 - InvestorPlace.com
The Trader Daily 7:30 a.m. June 11, 2014 - RealMoney.com
Biggest Movers in Healthcare Stocks Now – ISIS SGEN ARIA CLVS 7:30 a.m. June 10, 2014 - InvestorPlace.com
Cramer's Mad Money - Has Carl Icahn Lost His Mind? (6/9/14) 5:12 a.m. June 10, 2014 - Seeking Alpha
Target And Others Insiders Have Been Buying 1:30 p.m. June 8, 2014 - benzinga.com
The Trader Daily 7:30 a.m. June 5, 2014 - RealMoney.com
Hottest Healthcare Stocks Now – INCY OPK SGEN ACOR 2:00 p.m. June 3, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – NPSP ARIA PCRX AGN 7:00 a.m. June 2, 2014 - InvestorPlace.com
The Trader Daily 7:30 a.m. May 29, 2014 - RealMoney.com
'Mad Money' Lightning Round: Take Palo Alto Networks Over FireEye 6:00 a.m. May 29, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Plan for the Worst, Hope for the Best 8:04 p.m. May 28, 2014 - TheStreet.com
Cramer's Mad Money - Father Versus Son (5/27/14) 6:23 a.m. May 28, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Running With the Bull Market 8:17 p.m. May 27, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – ICLR PRXL MNKD SGEN 6:15 a.m. May 19, 2014 - InvestorPlace.com
Three Oversold Biotech Stocks That Could Have Gigantic Upside 7:41 a.m. May 15, 2014 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – SGEN CLVS NBIX MASI 7:30 a.m. May 12, 2014 - InvestorPlace.com
UPDATE: Bank Of America Upgrades Seattle Genetics 8:31 a.m. May 6, 2014 - benzinga.com
A New Breed of Targeted Cancer Therapeutics & Stem Cell Advancements; Effective ProDrug Therapeutics Approach for GenSpera 8:29 a.m. June 20, 2014 - PR Newswire - PRF
Quarterly Changes to the NASDAQ Q-50 Index 7:16 a.m. June 16, 2014 - GlobeNewswire
NDA Resubmission, Clinical Data and Findings, and Conference Participations - Analyst Notes on InterMune, ResMed, Seattle Genetics, Insulet and Charles River 6:30 a.m. June 5, 2014 - PR Newswire - PRF
Seattle Genetics Presents Data from Phase 1 Clinical Trial of Antibody-Drug Conjugate (ADC) SGN-CD19A in Non-Hodgkin Lymphoma at ASCO Annual Meeting 9:01 a.m. June 1, 2014 - BusinessWire - BZX
Seattle Genetics Highlights Data from Multiple Collaborator Antibody-Drug Conjugate (ADC) Programs at ASCO Annual Meeting 2:16 p.m. May 31, 2014 - BusinessWire - BZX
Technical Coverage on Health Care Sector Equities -- Research on Arena Pharma, Exelixis, Dendreon, and Seattle Genetics 7:40 a.m. May 30, 2014 - PR Newswire - PRF
Seattle Genetics to Present at Jefferies Global Healthcare Conference 9:01 a.m. May 29, 2014 - BusinessWire - BZX
Financial Results, Data Presentations, and Breakthrough Therapy Designation - Analyst Notes on Insys, Seattle Genetics, Cubist, Celldex and Clovis 7:10 a.m. May 22, 2014 - PR Newswire - PRF
Seattle Genetics and Collaborators Will Present Data from Multiple Antibody-Drug Conjugate (ADC) Programs at ASCO Annual Meeting 5:11 p.m. May 14, 2014 - BusinessWire - BZX
Clinical Study Results, Upcoming Events, and Financial Updates - Analyst Notes on Amgen, Insys, Alnylam, Seattle Genetics and Emergent BioSolutions 8:50 a.m. May 14, 2014 - PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Ironwood Pharma, Neurocrine Biosciences, Rigel Pharma, and Seattle Genetics 9:10 a.m. May 8, 2014 - PR Newswire - PRF
Seattle Genetics to Present at Upcoming Investor Conferences 9:03 a.m. May 7, 2014 - BusinessWire - BZX
The World Market for Orphan Drugs 6:59 p.m. April 29, 2014 - PR Newswire - PRF
Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014 12:09 p.m. April 29, 2014 - PR Newswire - PRF
Seattle Genetics to Host Conference Call and Webcast Discussion of First Quarter 2014 Financial Results on May 1, 2014 9:01 a.m. April 16, 2014 - BusinessWire - BZX
Premier Biomedical (BIEI) and the Wild West of Modern Medicine 10:26 a.m. April 14, 2014 - ACCESSWIRE
Biotech Stocks Coverage -- Research on Seattle Genetics, Theravance, Neurocrine Biosciences, and MiMedx 12:30 p.m. April 10, 2014 - PR Newswire - PRF
Seattle Genetics Achieves Milestones Under Collaboration with Takeda for Achieving First Commercial Sales of ADCETRIS® (Brentuximab Vedotin) in Key Countries 9:01 a.m. April 8, 2014 - BusinessWire - BZX
Seattle Genetics Highlights Antibody-Drug Conjugate (ADC) Program and Technology Advances at AACR 10:31 a.m. April 7, 2014 - BusinessWire - BZX
Quarterly Changes to the NASDAQ Q-50 Index 7:41 a.m. March 17, 2014 - GlobeNewswire
Fossil shares rise as earnings beat Street 6:55 p.m. Feb. 11, 2014 - Wallace Witkowski
December pullback triggers first technical test 12:33 p.m. Dec. 5, 2013 - Michael Ashbaugh
Six stocks to watch for some upside 3:21 p.m. April 11, 2013 - The Trading Deck
S&P 500 takes flight, reaches record territory 10:55 a.m. April 11, 2013 - Michael Ashbaugh
Five bullish charts to watch 4:15 p.m. March 7, 2013 - The Trading Deck
Thursday’s biggest movers; Apple at 5-month low 6:27 p.m. Nov. 8, 2012 - Sue Chang
Hot Stocks to watch 7:27 a.m. Aug. 9, 2012 - MarketWatch.com
2012 biotech medal winners ... so far 12:01 a.m. Aug. 1, 2012 - Gil Morales
12 biotech stocks hit 52-week highs 3:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three technical tests converge 10:40 a.m. July 18, 2012 - Michael Ashbaugh
MoKa's Morales sees Facebook, LinkedIn on cutting edge 12:34 p.m. June 25, 2012 - blogs.marketwatch.com
Tuesday’s biggest gaining and declining stocks 6:47 p.m. Feb. 14, 2012 - Sue Chang
Rackspace Hosting, Yingli rise after hours 6:44 p.m. Feb. 13, 2012 - Myra P. Saefong
Seattle Genetics falls on growth concerns 2:42 p.m. Nov. 4, 2011 - MarketWatch.com
ECB rattles the technical backdrop 10:45 a.m. Nov. 3, 2011 - Michael Ashbaugh
U.S. markets break from the “crash” range 12:19 p.m. Oct. 24, 2011 - Michael Ashbaugh
S&P 500 rattles the cage on a trend shift 10:35 a.m. Oct. 10, 2011 - Michael Ashbaugh
3 biotech stocks battle the ‘Dendreon Effect’ 7:50 p.m. Aug. 18, 2011 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 3:49 p.m. July 15, 2011 - Kate Gibson
Seattle Genetics slides 11% on drug launch worries 10:06 a.m. July 15, 2011 - Val Brickates Kennedy
Hottest Healthcare Stocks Now – ISIS CELG MDT COV 7:00 a.m. June 19, 2014 - InvestorPlace.com
Can the Rally in Seattle Genetics (SGEN) Shares Continue? - Tale of the Tape 9:52 a.m. June 12, 2014 - Zacks.com
Biotech Stocks Get Turbo Boost From Idenix Deal 6:45 p.m. June 11, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ALNY SGEN PBYI RDY 9:00 a.m. June 11, 2014 - InvestorPlace.com
The Trader Daily 7:30 a.m. June 11, 2014 - RealMoney.com
Biggest Movers in Healthcare Stocks Now – ISIS SGEN ARIA CLVS 7:30 a.m. June 10, 2014 - InvestorPlace.com
Cramer's Mad Money - Has Carl Icahn Lost His Mind? (6/9/14) 5:12 a.m. June 10, 2014 - Seeking Alpha
Target And Others Insiders Have Been Buying 1:30 p.m. June 8, 2014 - benzinga.com
The Trader Daily 7:30 a.m. June 5, 2014 - RealMoney.com
Hottest Healthcare Stocks Now – INCY OPK SGEN ACOR 2:00 p.m. June 3, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – NPSP ARIA PCRX AGN 7:00 a.m. June 2, 2014 - InvestorPlace.com
The Trader Daily 7:30 a.m. May 29, 2014 - RealMoney.com
'Mad Money' Lightning Round: Take Palo Alto Networks Over FireEye 6:00 a.m. May 29, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Plan for the Worst, Hope for the Best 8:04 p.m. May 28, 2014 - TheStreet.com
Cramer's Mad Money - Father Versus Son (5/27/14) 6:23 a.m. May 28, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Running With the Bull Market 8:17 p.m. May 27, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – ICLR PRXL MNKD SGEN 6:15 a.m. May 19, 2014 - InvestorPlace.com
Three Oversold Biotech Stocks That Could Have Gigantic Upside 7:41 a.m. May 15, 2014 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – SGEN CLVS NBIX MASI 7:30 a.m. May 12, 2014 - InvestorPlace.com
UPDATE: Bank Of America Upgrades Seattle Genetics 8:31 a.m. May 6, 2014 - benzinga.com
A New Breed of Targeted Cancer Therapeutics & Stem Cell Advancements; Effective ProDrug Therapeutics Approach for GenSpera 8:29 a.m. June 20, 2014 - PR Newswire - PRF
Quarterly Changes to the NASDAQ Q-50 Index 7:16 a.m. June 16, 2014 - GlobeNewswire
NDA Resubmission, Clinical Data and Findings, and Conference Participations - Analyst Notes on InterMune, ResMed, Seattle Genetics, Insulet and Charles River 6:30 a.m. June 5, 2014 - PR Newswire - PRF
Seattle Genetics Presents Data from Phase 1 Clinical Trial of Antibody-Drug Conjugate (ADC) SGN-CD19A in Non-Hodgkin Lymphoma at ASCO Annual Meeting 9:01 a.m. June 1, 2014 - BusinessWire - BZX
Seattle Genetics Highlights Data from Multiple Collaborator Antibody-Drug Conjugate (ADC) Programs at ASCO Annual Meeting 2:16 p.m. May 31, 2014 - BusinessWire - BZX
Technical Coverage on Health Care Sector Equities -- Research on Arena Pharma, Exelixis, Dendreon, and Seattle Genetics 7:40 a.m. May 30, 2014 - PR Newswire - PRF
Seattle Genetics to Present at Jefferies Global Healthcare Conference 9:01 a.m. May 29, 2014 - BusinessWire - BZX
Financial Results, Data Presentations, and Breakthrough Therapy Designation - Analyst Notes on Insys, Seattle Genetics, Cubist, Celldex and Clovis 7:10 a.m. May 22, 2014 - PR Newswire - PRF
Seattle Genetics and Collaborators Will Present Data from Multiple Antibody-Drug Conjugate (ADC) Programs at ASCO Annual Meeting 5:11 p.m. May 14, 2014 - BusinessWire - BZX
Clinical Study Results, Upcoming Events, and Financial Updates - Analyst Notes on Amgen, Insys, Alnylam, Seattle Genetics and Emergent BioSolutions 8:50 a.m. May 14, 2014 - PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Ironwood Pharma, Neurocrine Biosciences, Rigel Pharma, and Seattle Genetics 9:10 a.m. May 8, 2014 - PR Newswire - PRF
Seattle Genetics to Present at Upcoming Investor Conferences 9:03 a.m. May 7, 2014 - BusinessWire - BZX
The World Market for Orphan Drugs 6:59 p.m. April 29, 2014 - PR Newswire - PRF
Natural Killer Cell Lymphomas Global Clinical Trials Review, H1, 2014 12:09 p.m. April 29, 2014 - PR Newswire - PRF
Seattle Genetics to Host Conference Call and Webcast Discussion of First Quarter 2014 Financial Results on May 1, 2014 9:01 a.m. April 16, 2014 - BusinessWire - BZX
Premier Biomedical (BIEI) and the Wild West of Modern Medicine 10:26 a.m. April 14, 2014 - ACCESSWIRE
Biotech Stocks Coverage -- Research on Seattle Genetics, Theravance, Neurocrine Biosciences, and MiMedx 12:30 p.m. April 10, 2014 - PR Newswire - PRF
Seattle Genetics Achieves Milestones Under Collaboration with Takeda for Achieving First Commercial Sales of ADCETRIS® (Brentuximab Vedotin) in Key Countries 9:01 a.m. April 8, 2014 - BusinessWire - BZX
Seattle Genetics Highlights Antibody-Drug Conjugate (ADC) Program and Technology Advances at AACR 10:31 a.m. April 7, 2014 - BusinessWire - BZX
Quarterly Changes to the NASDAQ Q-50 Index 7:41 a.m. March 17, 2014 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼